• Associations between symptom and neurocognitive dimensions in clinical high risk for psychosis 

      Aase, Ingvild; Langeveld, Johannes Hendrik; Joa, Inge; Johannessen, Jan Olav; Dalen, Ingvild; Hegelstad, Wenche (Peer reviewed; Journal article, 2022)
      Introduction Clinical high risk for psychosis (CHR) is associated with mild cognitive impairments. Symptoms are clustered into positive, negative and disorganization symptoms. The association between specific symptom ...
    • Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT 

      Anda, Liss; Johnsen, Erik; Kroken, Rune A.; Joa, Inge; Rettenbacher, Maria; Løberg, Else-Marie (Peer reviewed; Journal article, 2021)
      Cognitive impairment is a core aspect of psychotic disorders and difficult to treat. Atypical antipsychotics (AAs) might have differential effects on cognitive impairment, but rigid study designs and selective sampling ...
    • Cognitive predictors of longitudinal positive symptom course in clinical high risk for psychosis 

      Aase, Ingvild; Langeveld, Johannes Hendrik; Johannessen, Jan Olav; Joa, Inge; Dalen, Ingvild; Hegelstad, Wenche (Peer reviewed; Journal article, 2021)
      Background Clinical High Risk (CHS) for psychosis is a state in which positive symptoms are predominant but do not reach a level of severity that fulfils the criteria for a psychotic episode. The aim of this study has ...